New COVID-19 Vaccine Errors Or Hazards
After the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to both the Pfizer-BioNTech and Moderna coronavirus disease 2019 (COVID-19) vaccines, ISMP…
Pfizer
Pfizer Breakthrough Growth Initiative And $120 Million Investment
On January 12, Pfizer Inc. announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies…
Pfizer and BioNTech Supply Another 100 Million Doses of COVID-19 Vaccine
Right before Christmas Pfizer Inc. and BioNTech SE announced a second agreement with the U.S. government to supply an additional 100 million doses of the…
MRNA COVID-19 Vaccines Interim Clinical Considerations
After the approving of Pfizer-BioNTech and Moderna COVID-19 vaccines the Advisory Committee on Immunization Practices (ACIP) has issued vaccines interim clinical considerations for the prevention…
Walgreens Begins Administration Of Pfizer’s COVID-19 Vaccine
On December 18, Walgreens announced about beginning Pfizer’s COVID-19 vaccine administering to residents and staff at long-term care facilities. Pharmacists are providing the vaccinations at…
Pfizer And Biontech Potential First EUA For Vaccine
On December 10 FDA (Food and Drug Administration) holds an advisory committee meeting to discuss authorization of COVID-19 vaccine candidate (vaccine from Pfizer and Biontech)…
Emergency Use Authorization For COVID-19 Vaccine Discussed By VRBPAC
Recently, The U.S. Food and Drug Administration (FDA) posted online background material for this week’s upcoming Vaccines and Related Biological Products Advisory Committee (VRBPAC) public…
Pfizer And Biontech EUA For COVID-19 Vaccine
On November 20, Pfizer Inc. and BioNTech SE announced they will submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use…
Pfizer, BioNTech COVID-19 Vaccine
In an open letter, October 16, Pfizer chairman and CEO Albert Bourla, announced that BioNTech COVID-19 vaccine will be ready for FDA submission by late…